US

Alexander D D'addio

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander D D'addio. Retrieved from https://idiyas.com/inventor/alexander-d-d-addio-raxmdd31

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Alexander D D'addio: Innovator in Pharmaceutical Compositions

Introduction

Alexander D D'addio is a notable inventor in the field of pharmaceuticals, particularly recognized for his work on compositions that include azelastine. His innovative approach aims to enhance patient experience and compliance through improved formulations.

Latest Patents

Although Alexander D D'addio currently holds 0 patents, his significant contribution is encapsulated in his invention titled "Compositions Comprising Azelastine And Methods Of Use Thereof." This invention provides pharmaceutical compositions that include azelastine or its pharmaceutically acceptable salts or esters, such as azelastine hydrochloride. The compositions are designed to reduce post-nasal drip and mask the unpleasant bitter taste associated with such conditions.

Career Highlights

Alexander D D'addio is associated with Meda Pharmaceuticals Inc., where he has contributed to the development of pharmaceutical solutions aimed at treating allergic rhinitis, non-allergic vasomotor rhinitis, and allergic conjunctivitis. His work emphasizes patient acceptability and convenience, which are crucial in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Phuong Grace Dang and Brian D Lawrence, who have likely collaborated with him on various projects within Meda Pharmaceuticals Inc.

Conclusion

Alexander D D'addio's contributions to pharmaceutical compositions reflect his commitment to improving patient care through innovative solutions. His work continues to influence the field, showcasing the importance of effective formulations in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…